Results 141 to 150 of about 3,185 (206)
Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline. [PDF]
Alzheimers Res Thervan der Schaar J, van der Flier WM, Visser LNC, van de Giessen E, van Harten AC, Sikkes SAM, van Leeuwenstijn-Koopman MSSA, Hendriksen HMA, Trieu C, Bredenoord AL, van den Hoven MA, Asscher ECA. +11 moreeuropepmc +1 more sourceThe impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study. [PDF]
Alzheimers Res TherVermeiren MR, Somsen J, Luurtsema G, Reesink FE, Verwey NA, Hempenius L, Tolboom N, Biessels GJ, Biesbroek JM, Vernooij MW, Veldhuijzen van Zanten SEM, Seelaar H, Coomans EM, Teunissen CE, Lemstra AW, van Harten AC, Visser LNC, van der Flier WM, van de Giessen E, Ossenkoppele R. +19 moreeuropepmc +1 more sourceThe relationship between cognitive screeners and everyday functioning in amyloid-positive participants from the Amsterdam Dementia Cohort. [PDF]
Alzheimers Dement (Amst)van der Putten-Toorenburg A, Butterbrod E, Schalet BD, van der Veere PJ, Tewolde ME, Postema MC, van de Giessen E, Teunissen CE, van Harten AC, van der Flier WM, Sikkes SAM. +10 moreeuropepmc +1 more sourceMulti-Cohort Federated Learning Shows Synergy in Mortality Prediction for MRI-Based and Metabolomics-Based Age Scores. [PDF]
J Healthc Inform ResMateus P, Garst S, Yu J, Cats D, Harms AGJ, Birhanu M, Beekman M, Slagboom PE, Reinders M, van der Grond J, Dekker A, Jansen JFA, Beran M, Schram MT, Visser PJ, Moonen J, Ghanbari M, Roshchupkin G, Vojinovic D, Bermejo I, Mei H, Bron EE. +21 moreeuropepmc +1 more sourceTime’s up: Using data-driven phenotype-severity metrics not time to map progression in the dementias
Smith V, Schumacher R, Ramanan S, Bouzigues A, Russell LL, Foster PH, Ferry-Bolder E, van Swieten JC, Jiskoot LC, Seelaar H, Sanchez-Valle R, Laforce R, Graff C, Galimberti D, Vandenberghe R, de Mendonça A, di Fede G, Santana I, Gerhard A, Levin J, Nacmias B, Otto M, Bertoux M, Lebouvier T, Ducharme S, Butler CR, Le Ber I, Finger E, Tartaglia MC, Masellis M, Synofzik M, Moreno F, Borroni B, Rohrer JD, Rowe JB, Lambon Ralph MA. +35 moreeuropepmc +1 more sourceThalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI study. [PDF]
Brain CommunSoskic S, Tregidgo HFJ, Todd EG, Bouzigues A, Cash DM, Russell LL, Thomas DL, Malone IB, Foster PH, Ferry-Bolder E, van Swieten JC, Jiskoot LC, Seelaar H, Sanchez-Valle R, Laforce R, Graff C, Galimberti D, Vandenberghe R, de Mendonça A, Tiraboschi P, Santana I, Gerhard A, Levin J, Nacmias B, Otto M, Bertoux M, Lebouvier T, Ducharme S, Butler CR, Le Ber I, Finger EC, Tartaglia MC, Masellis M, Rowe JB, Synofzik M, Moreno F, Borroni B, Alexander DC, Iglesias JE, Rohrer JD, Bocchetta M, GENetic Frontotemporal dementia Initiative (GENFI) . +41 moreeuropepmc +1 more sourceReal-world diagnostic performance of blood-based biomarkers for Alzheimer's disease: robust performance except after stroke and high charlson comorbidity index. [PDF]
Alzheimers Res TherVigneswaran S, Verberk IMW, Rousset RZ, Gouda M, Trieu C, Claessen T, de Giessen EV, Lemstra AW, Wilson D, Pijnenburg YAL, Flier WMV, Teunissen CE, Harten ACV. +12 moreeuropepmc +1 more sourceA human iPSC-based perfusable and membrane-free neurovascular unit-on-chip connecting brain organoids to the blood-brain barrier.
Lab ChipNogueira Pinto H, Kistemaker L, Ponomarenko M, Ermakov AA, Karsten-van Diepen M, van der Pol SMA, Pasterkamp RJ, Beekhuis-Hoekstra SD, de Wit NM, van Bodegraven EJ, de Vries HE, Hol EM. +11 moreeuropepmc +1 more source
